News on NGS technologies, RNA-seq, clinical sequencing, & sample prep in genetics, genomics, and molecular diagnostics.
The suit names additional defendants and includes additional details about the technology Illumina is accused of appropriating.
While the New York Genome Center says whole-genome cancer sequencing is the future, companies already offering such tests are struggling to get paid.
Using sequences from a 4,900-year-old Swedish gravesite, researchers identified a pathogenic form of Yersinia pestis circulating in Europe during the Neolithic Period.
DNA sequence data from 416 neuroblastoma cases led to informative alterations affecting genes from telomere maintenance, RAS, or TP53 pathways.
The company said that 20 medical centers in the US are now offering the Envisia Genomic Classifier through an early-access program begun in May.
